World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000626561
Date of registration: 16/06/2015
Prospective Registration: Yes
Primary sponsor: Sariyer Hamidiye Etfal Training and Research Hospital
Public title: Haemodynamic and Respiratory Effects of Volume-Controlled Versus Pressure-Controlled Ventilation During Gynecologic Surgery
Scientific title: Haemodynamic and Respiratory Effects of Volume-Controlled Versus Pressure-Controlled Ventilation During Gynecologic Laparoscopic Surgery in Steep Trendelenburg Position
Date of first enrolment: 03/06/2019
Target sample size: 60
Recruitment status: Not yet recruiting
URL:  https://anzctr.org.au/ACTRN12615000626561.aspx
Study type:  Interventional
Study design:  Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Parallel;Type of endpoint: Safety;  
Phase:  Not Applicable
Countries of recruitment
Turkey
Contacts
Name: Dr NESRIN AHU ASLAN   
Address:  Zekeriyakoy Mahallesi Basin Yayin Sitesi Erguvan Sokak No:16 34450 Sariyer Istanbul Turkey Turkey
Telephone: +90 532 3965678
Email: DRAHUASLAN@YAHOO.COM
Affiliation: 
Name: Dr NESRIN AHU ASLAN   
Address:  Zekeriyakoy Mahallesi Basin Yayin Sitesi Erguvan Sokak No:16 34450 Sariyer Istanbul Turkey Turkey
Telephone: +90 532 3965678
Email: DRAHUASLAN@YAHOO.COM
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: ASA physical status I-II
Robotic gynaecologic surgery patients

Exclusion criteria: Valvular heart disease
Abnormal regional wall contraction in echocardiography
Pericardial disease
Dilated cardiomyopathy
Left atrial dialtation
Left ventricular dilatation
Obstructive/restrictive lung disease
Body mass index>30
Eosophageal disease/dysphagia
Blood loss leading more than %10 decrease in MAP


Age minimum: 18 Years
Age maximum: 60 Years
Gender: Females
Health Condition(s) or Problem(s) studied
Anaesthesiology - Other anaesthesiology
ENDOMETRIUM CARCINOMA;CERVIX CARCINOMA;MYOMA UTERI;UTERINE PROLAPSUS;
ENDOMETRIUM CARCINOMA
CERVIX CARCINOMA
MYOMA UTERI
UTERINE PROLAPSUS
Surgery - Other surgery
Intervention(s)
Mechanical ventilation mode:
PCV is an alternative mode of ventilation to VCV that is widely used in patients with elevated intraabdominal pressure and it has been shown to improve arterial oxygenation and decrease the peak airway pressure because of its decelerating inspiratory flow.

Mechanical ventilation will be administered continuously from induction of anesthesia until extubation. In the pressure-controlled group, the peak airway pressure not exceeding 35 cmH2O will be set to provide a tidal volume of 8 ml/kg, with and I:E ratio of 1:1,5. The respiratory rate will be adjusted to obtain an end-tidal CO2 of 35-40 cmH2O to be started with a respiratory rate of 12/min.
Primary Outcome(s)
Cardiac output by using picco[Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)]
Mean peak airway pressure
Lower peak airway pressure levels are expected on respiratory monitor[Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)
]
Secondary Outcome(s)
Arterial carbondioxide level by arterial blood gas analysis[Baseline (t-zero)
After pneumoperitoneum (t1)
After 45 degree trendelenburg (t2)
15 (t3), 45 (t4), 90 (t5) minutes later
End of surgery (t6)]
Secondary ID(s)
NONE
Source(s) of Monetary Support
Secondary Sponsor(s)
Not applicable
Ethics review
Status: Approved
Approval date:
Contact:
Istanbul Medipol University Interventional Clinical Trials Ethics Commitee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history